| Literature DB >> 29133597 |
Andrea Farioli1, Kurt Straif2, Giovanni Brandi3,4, Stefania Curti1, Kristina Kjaerheim5, Jan Ivar Martinsen5, Pär Sparen6, Laufey Tryggvadottir7,8, Elisabete Weiderpass5,6,9,10, Guido Biasco3,4, Francesco Saverio Violante1, Stefano Mattioli1, Eero Pukkala11,12.
Abstract
OBJECTIVES: To assess the association between occupational exposure to asbestos and the risk of cholangiocarcinoma (CC).Entities:
Mesh:
Substances:
Year: 2017 PMID: 29133597 PMCID: PMC5869450 DOI: 10.1136/oemed-2017-104603
Source DB: PubMed Journal: Occup Environ Med ISSN: 1351-0711 Impact factor: 4.402
Figure 1Flow diagram of the study population.
Characteristics of the study population
| All cholangiocarcinoma* | Intrahepatic cholangiocarcinoma* | Extrahepatic cholangiocarcinoma* | ||||
| Cases | Controls | Cases | Controls | Cases | Controls | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Gender | ||||||
| Female | 4317 (52.5) | 18 268 (48.9) | 674 (46.2) | 2937 (43.4) | 1783 (44.9) | 7523 (41.3) |
| Male | 3914 (47.5) | 19 121 (51.1) | 784 (53.8) | 3836 (56.6) | 2189 (55.1) | 10 698 (58.7) |
| Birth cohort | ||||||
| 1920–1929 | 4416 (53.7) | 19 266 (51.5) | 654 (44.9) | 2929 (43.3) | 2156 (54.3) | 9553 (52.4) |
| 1930–1939 | 2322 (28.2) | 10 939 (29.3) | 415 (28.5) | 1971 (29.1) | 1116 (28.1) | 5288 (29.0) |
| 1940–1949 | 1177 (14.3) | 5665 (15.1) | 296 (20.3) | 1426 (21.0) | 549 (13.8) | 2651 (14.6) |
| 1950–1960 | 316 (3.8) | 1519 (4.1) | 93 (6.4) | 447 (6.6) | 151 (3.8) | 729 (4.0) |
| Reference age† | ||||||
| ≤59 | 2736 (33.2) | 12 800 (34.2) | 538 (36.9) | 2542 (37.5) | 1412 (35.5) | 6604 (36.2) |
| 60–69 | 3003 (36.5) | 13 593 (36.4) | 502 (34.4) | 2320 (34.3) | 1416 (35.7) | 6507 (35.7) |
| ≥70 | 2492 (30.3) | 10 996 (29.4) | 418 (28.7) | 1911 (28.2) | 1144 (28.8) | 5110 (28.0) |
| Reference period‡ | ||||||
| 1961–1970 | 21 (0.3) | 94 (0.3) | 0 (0.0) | 0 (0.0) | 17 (0.4) | 77 (0.4) |
| 1971–1980 | 451 (5.5) | 1959 (5.2) | 46 (3.2) | 194 (2.9) | 256 (6.5) | 1141 (6.3) |
| 1981–1990 | 1796 (21.8) | 8012 (21.4) | 266 (18.2) | 1208 (17.8) | 979 (24.6) | 4408 (24.2) |
| 1991–2005 | 5963 (72.4) | 27 324 (73.1) | 1146 (78.6) | 5371 (79.3) | 2720 (68.5) | 12 595 (69.1) |
| Country | ||||||
| Finland | 3395 (41.2) | 15 306 (40.9) | 549 (37.7) | 2571 (38.0) | 1353 (34.1) | 6214 (34.1) |
| Iceland | 73 (0.9) | 305 (0.8) | 11 (0.7) | 48 (0.7) | 43 (1.1) | 186 (1.0) |
| Norway | 1349 (16.4) | 5870 (15.7) | 260 (17.8) | 1153 (17.0) | 610 (15.4) | 2699 (14.8) |
| Sweden | 3414 (41.5) | 15 908 (42.6) | 638 (43.8) | 3001 (44.3) | 1966 (49.5) | 9122 (50.1) |
| Ever worked in the printing industry | ||||||
| No | 8138 (98.9) | 36 979 (98.9) | 1426 (97.8) | 6703 (99.0) | 3933 (99.0) | 18 002 (98.8) |
| Yes | 93 (1.1) | 410 (1.1) | 32 (2.2) | 70 (1.0) | 39 (1.0) | 219 (1.2) |
| Occupational exposure to asbestos | ||||||
| No | 6861 (83.4) | 31 052 (83.0) | 1171 (80.3) | 5548 (81.9) | 3225 (81.2) | 14 727 (80.8) |
| Yes | 1370 (16.6) | 6337 (17.0) | 287 (19.7) | 1225 (18.1) | 747 (18.8) | 3494 (19.2) |
*2801 cases (1860 women and 941 men) were classified as cholangiocarcinoma but the coding scheme did not allow the distinction between intra- and extrahepatic cholangiocarcinoma. These cases are included in the ‘All cholangiocarcinoma’ column.
†Reference age defined as age at diagnosis for cases and age at sampling for controls.
‡Reference period defined as period of diagnosis for cases and period of sampling for controls.
Occupational exposure to asbestos and risk of cholangiocarcinoma
| Metric for occupational exposure to asbestos | All cholangiocarcinoma | Intrahepatic cholangiocarcinoma | Extrahepatic cholangiocarcinoma | |||||||||
| Cases | Controls | OR (95% CI) | p trend | Cases | Controls | OR (95% CI) | p trend | Cases | Controls | OR (95% CI) | p trend | |
| Never/ever exposed | ||||||||||||
| Never | 6861 | 31 052 | 1.0 (Ref) | 1171 | 5548 | 1.0 (Ref) | 3225 | 14 727 | 1.0 (Ref) | |||
| Ever | 1370 | 6337 | 1.1 (1.0 to 1.1) | 287 | 1225 | 1.2 (1.0 to 1.4) | 747 | 3494 | 1.1 (1.0 to 1.2) | |||
| Maximum intensity* | ||||||||||||
| 0 f/mL | 6861 | 31 052 | 1.0 (Ref) | 1171 | 5548 | 1.0 (Ref) | 3225 | 14 727 | 1.0 (Ref) | |||
| <0.11 f/mL | 786 | 3605 | 1.1 (1.0 to 1.2) | 147 | 735 | 1.0 (0.8 to 1.3) | 443 | 1950 | 1.1 (1.0 to 1.3) | |||
| 0.11–0.79 f/mL | 321 | 1550 | 1.0 (0.9 to 1.2) | 77 | 286 | 1.4 (1.1 to 1.8) | 171 | 877 | 1.0 (0.8 to 1.1) | |||
| ≥0.80 f/mL | 263 | 1182 | 1.1 (0.9 to 1.3) | 0.115 | 63 | 204 | 1.6 (1.2 to 2.2) | 0.001 | 133 | 667 | 1.0 (0.8 to 1.2) | 0.853 |
| Duration of exposure* | ||||||||||||
| 0 years | 6861 | 31 052 | 1.0 (Ref) | 1171 | 5548 | 1.0 (Ref) | 3225 | 14 727 | 1.0 (Ref) | |||
| <21 years | 678 | 3180 | 1.1 (1.0 to 1.2) | 149 | 632 | 1.2 (1.0 to 1.5) | 372 | 1763 | 1.0 (0.9 to 1.2) | |||
| 22–41 years | 545 | 2532 | 1.1 (1.0 to 1.2) | 111 | 477 | 1.2 (1.0 to 1.5) | 297 | 1394 | 1.0 (0.9 to 1.2) | |||
| ≥42 years | 147 | 625 | 1.2 (1.0 to 1.4) | 0.051 | 27 | 116 | 1.2 (0.8 to 1.9) | 0.040 | 78 | 337 | 1.2 (0.9 to 1.5) | 0.222 |
| Cumulative exposure* | ||||||||||||
| 0 f/mL × years | 6861 | 31 052 | 1.0 (Ref) | 1171 | 5548 | 1.0 (Ref) | 3225 | 14 727 | 1.0 (Ref) | |||
| 0.1–1.1 f/mL × years | 699 | 3133 | 1.1 (1.0 to 1.2) | 144 | 641 | 1.2 (0.9 to 1.4) | 377 | 1688 | 1.1 (1.0 to 1.2) | |||
| 1.2–14.9 f/mL × years | 522 | 2595 | 1.0 (0.9 to 1.1) | 109 | 480 | 1.2 (0.9 to 1.5) | 296 | 1476 | 1.0 (0.9 to 1.1) | |||
| ≥15.0 f/mL × years | 149 | 609 | 1.2 (1.0 to 1.4) | 0.122 | 34 | 104 | 1.7 (1.1 to 2.5) | 0.007 | 74 | 330 | 1.1 (0.8 to 1.4) | 0.482 |
| Cumulative exposure† | ||||||||||||
| 0 f/mL × years | 6861 | 31 052 | 1.0 (Ref) | 1171 | 5548 | 1.0 (Ref) | 3225 | 14 727 | 1.0 (Ref) | |||
| 0.1–4.9 f/mL × years | 969 | 4534 | 1.1 (1.0 to 1.1) | 199 | 927 | 1.1 (0.9 to 1.3) | 536 | 2447 | 1.1 (1.0 to 1.2) | |||
| 5.0–9.9 f/mL × years | 142 | 704 | 1.0 (0.8 to 1.2) | 27 | 106 | 1.3 (0.8 to 2.0) | 81 | 444 | 0.9 (0.7 to 1.2) | |||
| 10.0–14.9 f/mL × years | 110 | 490 | 1.1 (0.9 to 1.4) | 27 | 88 | 1.6 (1.0 to 2.5) | 56 | 273 | 1.0 (0.8 to 1.4) | |||
| ≥15.0 f/mL × years | 149 | 609 | 1.2 (1.0 to 1.4) | 0.033 | 34 | 104 | 1.7 (1.1 to 2.5) | 0.001 | 74 | 330 | 1.1 (0.8 to 1.4) | 0.503 |
Estimates from logistic regression models conditioned on matching variables (year of birth, gender and country).
*Cut-offs based on quartile of the distribution of the exposure among subjects with a non-zero exposure.
†Equal intervals.
Ref, reference category.
Cumulative exposure to asbestos and risk of intrahepatic cholangiocarcinoma: comparison of unlagged/lagged exposure metrics
| Lag period | Cases | Controls | OR (95% CI) | p trend | BIC |
| No lag | 0.004 | 5036.3 | |||
| 0 f/mL × years | 1171 | 5548 | 1.0 (Ref) | ||
| 0.1–1.1 f/mL × years | 144 | 641 | 1.2 (1.0 to 1.4) | ||
| 1.2–14.9 f/mL × years | 109 | 480 | 1.2 (1.0 to 1.5) | ||
| ≥15.0 f/mL × years | 34 | 104 | 1.7 (1.1 to 2.6) | ||
| 10-year lag | 0.006 | 5037.6 | |||
| 0 f/mL × years | 1177 | 5564 | 1.0 (Ref) | ||
| 0.1–1.1 f/mL × years | 143 | 641 | 1.2 (0.9 to 1.4) | ||
| 1.2–14.9 f/mL × years | 108 | 474 | 1.2 (1.0 to 1.5) | ||
| ≥15.0 f/mL × years | 30 | 94 | 1.7 (1.1 to 2.6) | ||
| 20-year lag | 0.003 | 5035.4 | |||
| 0 f/mL × years | 1196 | 5663 | 1.0 (Ref) | ||
| 0.1–1.1 f/mL × years | 133 | 586 | 1.2 (1.0 to 1.5) | ||
| 1.2–14.9 f/mL × years | 110 | 477 | 1.2 (1.0 to 1.5) | ||
| ≥15.0 f/mL × years | 19 | 47 | 2.1 (1.2 to 3.7) | ||
| 30-year lag | 0.023 | 5040.3 | |||
| 0 f/mL × years | 1259 | 5923 | 1.00 (Ref) | ||
| 0.1–1.1 f/mL × years | 102 | 454 | 1.2 (0.9 to 1.5) | ||
| 1.2–14.9 f/mL × years | 94 | 389 | 1.3 (1.0 to 1.6) | ||
| ≥15.0 f/mL × years | 3 | 7 | 2.3 (0.6 to 8.8) |
Estimates from logistic regression models conditioned on matching variables (year of birth, gender and country).
BIC, Bayesian information criterion; Ref, reference category.